Microbix Biosystems (TSE:MBX) stock price is above its 50-day moving average of $0.34

Share price of Microbix Biosystems Inc. (TSE:MBX – Get Your Free Report ) broke above its 50-day moving average during trading on Wednesday. The stock has a 50-day moving average of $0.34 and traded as high as $0.37. Shares of Microbix Biosystems last traded at $0.35 with a volume of 38,900 shares.

Microbix Biosystems Stock Performance

The stock has a market cap of $47.85 million, a PE ratio of 8.75 and a beta of 0.37. The company has a quick ratio of 5.57, a current ratio of 6.62, and a debt-to-equity ratio of 22.68. The firm has a 50-day moving average price of $0.34 and a 200-day moving average price of $0.34.

Insider Trading at Microbix Biosystems

In other news, insider Microbix Biosystems Inc. acquired 600,359 shares of Microbix Biosystems stock in a transaction dated Friday, August 30th. The stock was purchased at an average cost of $0.34 per share, for a total transaction of $204,122.06. Company insiders own 14.55% of the company’s shares.

Microbix Biosystems Company Profile

(Get a free report)

Microbix Biosystems Inc, a life sciences company, develops and markets proprietary biological and technological solutions for human health and well-being in North America, Europe and internationally. The company manufactures diagnostic-test products such as control tests under the QAPs brand; viral transport medium for the collection of patient samples to test pathogens, including the virus that causes the disease COVID-19 under the DxTM brand; Kinlytic, a biologic thrombolytic drug used to treat blood clots; and antigen products.

Read more

Get daily news and reviews for Microbix Biosystems – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Microbix Biosystems and related companies with MarketBeat.com’s FREE daily email newsletter.